Recent Student Publications


  1. T Sweezy, SA Mousa (2014) Genotype-Guided Use of Oral Antithrombotic Therapy: A Pharmacoeconomic Perspective. Personalized Medicine 11:223-235.
  2. M Thomas, SS Mousa, SA Mousa (2013) Comparative Effectiveness of Aflibercept for the Treatment of Patients with Neovascular Age-Related Macular Degeneration. Clinical Ophthalmology 7:495-501.
  3. NE Larche, SA Mousa (2013) Riociguat for the Management of Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension. Drugs of Today (Barc) 49:761-768.
  4. T Khushnud, SA Mousa (2013) Potential Role of Naturally Derived Polyphenols and Their Nanotechnology Delivery in Cancer. Molecular Biotechnology 55:78-86.
  5. AY Kardys, DJ Bharali, SA Mousa (2013) Amino-Functionalized Silica Nanoparticles: In Vitro Evaluation for Targeted Delivery and Therapy of Pancreatic Cancer. Journal of Nanotechnology DOI 10.1155/2013/768724.
  6. J Jalaly, J Dalfino, SA Mousa (2013) Onyx(R) in the Management of Cranial Arteriovenous Malformations. Expert Review of Medical Devices 10:453-459.
  7. SS Azad, ER Isenovic, S Yaturu, SA Mousa (2013) Insulin Therapy for Diabetes. In: Masuo K (ed) Type 2 Diabetes. InTech, DOI 10.5772/56379.
  8. CW Yang, SA Mousa (2012) The Effect of Red Yeast Rice (Monascus Purpureus) in Dyslipidemia and Other Disorders. Complementary Therapies in Medicine 20:466-474.
  9. D Swanson, R Block, SA Mousa (2012) Omega-3 Fatty Acids EPA and DHA: Health Benefits Throughout Life. Advances in Nutrition 3:1-7.
  10. J Stanekzai, ER Isenovic, SA Mousa (2012) Treatment Options for Diabetes: Potential Role of Stem Cells. Diabetes Research and Clinical Practice 98:361-368.
  11. NJ Rogers, SA Mousa (2012) The Shortcomings of Clinical Trials Assessing the Efficacy of Probiotics in Irritable Bowel Syndrome. Journal of Alternative and Complementary Medicine 18:112-119.
  12. H Patel, M Qari, SA Mousa (2012) Iron Balance in Β-Thalassemia: Maintaining an Antioxidant / Oxidant Ratio. Journal of Applied Hematology 3:4-11. Iron Balance in B-Thalassemia
  13. S Pabani, SA Mousa (2012) Current and Future Treatment of Pulmonary Hypertension. Drugs of Today 48:133-147.
  14. JC Keimer, SA Mousa (2012) Expanding the Role of Community Pharmacy: An Evaluation of Generic Drug Discount Programs, Pharmacy Based Immunization Services and Convenient Care Clinics. International Journal of Pharmacy 2:1-7.  Expanding the Role of Community Pharmacy
  15. G Beidoe, SA Mousa (2012) Current Primary Open-Angle Glaucoma Treatments and Future Directions. Clinical Ophthalmology 6:1699-1707.
  16. W Aman, S Mousa, G Shiha, SA Mousa (2012) Current Status and Future Directions in the Management of Chronic Hepatitis C. Virology Journal 9:57.
  17. J Ramli, P CalderonArtero, RC Block, SA Mousa (2011) Novel Therapeutic Targets for Preserving a Healthy Endothelium: Strategies for Reducing the Risk of Vascular and Cardiovascular Disease. Cardiology Journal 18:352-363.
  18. D Laurenzo, SA Mousa (2011) Mechanisms of Drug Resistance in Mycobacterium Tuberculosis and Current Status of Rapid Molecular Diagnostic Testing. Acta Tropica 119:5-10. Mechanisms of Drug Resistance in Mycobacterium Tuberculosis
  19. S Clayton, SA Mousa (2011) Therapeutics Formulated to Target Cancer Stem Cells: Is It in Our Future? Cancer Cell International 11:7.
  20. J-Y Byun, SA Mousa (2011) Thromboprophylaxis in Cancer Patients Receiving Bevacizumab. Journal of Applied Hematology 2:273-279. Thromboprophylaxis in Cancer Patients Receiving Bevacizumab

Recent Publications by Dr. Mousa and PRI Staff

  • A Bani-Jaber, H Cui, A Elsaid, M Yalcin, T Sudha, SA Mousa (2015) Pegylated Solid Lipid Nanoparticles Reconstituted From High-Density Lipoprotein components for Hepatic Targeting. ScienceJet Jan 19, 2015 [Epub ahead of print].
  • PJ Davis, GV Glinsky, HY Lin, JT Leith, A Hercbergs, HY Tang, O Ashur-Fabian, S Incerpi, SA Mousa (2015) Cancer Cell Gene Expression Modulated from Plasma Membrane Integrin αvβ3 by Thyroid Hormone and Nanoparticulate Tetrac. Front Endocrinol 5:240.
  • A Alshaiban, V Muralidharan-Chari, A Nepo, SA Mousa (2015) Modulation of Sickle Red Blood Cell Adhesion and Its Associated Changes in Biomarkers by Sulfated Nonanticoagulant Heparin Derivative. Clin Appl Thromb Hemost Jan 19, 2015 [Epub ahead of print].
  • R Alyahya, T Sudha, M Racz, SC Stain, SA Mousa (2015) Anti-Metastasis Efficacy and Safety of Non-Anticoagulant Heparin Derivative Versus Low Molecular Weight Heparin in Surgical Pancreatic Cancer Models. Int J Oncol 46:1225-1231.
  • AB Shirode, DJ Bharali, S Nallanthighal, JK Coon, SA Mousa, R Reliene (2015) Nanoencapsulation of Pomegranate Bioactive Compounds for Breast Cancer Chemoprevention. Int J Nanomedicine 10:475-484.
  • PJ Davis, HY Lin, T Sudha, M Yalcin, HY Tang, A Hercbergs, JT Leith, MK Luidens, O Ashur-Fabian, S Incerpi, SA Mousa (2014) Nanotetrac Targets Integrin Alphavbeta3 on Tumor Cells to Disorder Cell Defense Pathways and Block Angiogenesis. Onco Targets Ther 7:1619-1624. Nanotetrac Targets Integrin Alphavbeta3 on Tumor Cells
  • IA Siddiqui, DJ Bharali, M Nihal, VM Adhami, N Khan, JC Chamcheu, MI Khan, S Shabana, SA Mousa, H Mukhtar (2014) Excellent Anti-Proliferative and Pro-Apoptotic Effects of (-)-Epigallocatechin-3-Gallate Encapsulated in Chitosan Nanoparticles on Human Melanoma Cell Growth Both in Vitro and in Vivo. Nanomedicine 10:1619-1626.
  • T Sudha, M Yalcin, HY Lin, AM Elmetwally, T Nazeer, T Arumugam, P Phillips, SA Mousa (2014) Suppression of Pancreatic Cancer by Sulfated Non-Anticoagulant Low Molecular Weight Heparin. Cancer Letters 350:25-33.
  • SA Mousa, HY Lin, HY Tang, A Hercbergs, MK Luidens, PJ Davis (2014) Modulation of Angiogenesis by Thyroid Hormone and Hormone Analogues: Implications for Cancer Management. Angiogenesis 17:463-469.
  • N Khan, DJ Bharali, VM Adhami, IA Siddiqui, H Cui, SM Shabana, SA Mousa, H Mukhtar (2014) Oral Administration of Naturally Occurring Chitosan-Based Nanoformulated Green Tea Polyphenol Egcg Effectively Inhibits Prostate Cancer Cell Growth in a Xenograft Model. Carcinogenesis 35:415-423.

  1. M Yalcin, HY Lin, T Sudha, DJ Bharali, R Meng, HY Tang, FB Davis, SC Stain, PJ Davis, SA Mousa (2013) Response of Human Pancreatic Cancer Cell Xenografts to Tetraiodothyroacetic Acid Nanoparticles. Hormones and Cancer 4:176-185.
  2. A Rebbaa, G Patil, M Yalcin, T Sudha, SA Mousa (2013) Ot-404, Multi-Targeted Anti-Cancer Agent Affecting Tumor Proliferation, Chemo-Resistance, and Angiogenesis. Cancer Letters 332:55-62.
  3. SA Mousa (2013) Comparative Pharmacodynamic Assessment of the Antiangiogenesis Activity of Heparin and Low-Molecular-Weight Heparin Fractions: Structure-Function Relationship. Clinical and Applied Thrombosis/Hemostasis 19:48-54.
  4. AA Lugade, DJ Bharali, V Pradhan, G Elkin, SA Mousa, Y Thanavala (2013) Single Low-Dose Un-Adjuvanted Hbsag Nanoparticle Vaccine Elicits Robust, Durable Immunity. Nanomedicine 9:923-934.
  5. HY Lin, YF Su, MT Hsieh, S Lin, R Meng, D London, C Lin, HY Tang, J Hwang, FB Davis, SA Mousa, PJ Davis (2013) Nuclear Monomeric Integrin Alphav in Cancer Cells Is a Coactivator Regulated by Thyroid Hormone. FASEB Journal 27:3209-3216.
  6. PJ Davis, SA Mousa, V Cody, HY Tang, HY Lin (2013) Small Molecule Hormone or Hormone-Like Ligands of Integrin Alphavbeta3: Implications for Cancer Cell Behavior. Hormes and Cancer 4:335-342.
  7. PJ Davis, HY Lin, HY Tang, FB Davis, SA Mousa (2013) Adjunctive Input to the Nuclear Thyroid Hormone Receptor from the Cell Surface Receptor for the Hormone. Thyroid 23:1503-1509.
  8. PJ Davis, GV Glinsky, HY Lin, S Incerpi, FB Davis, SA Mousa, HY Tang, A Hercbergs, MK Luidens (2013) Molecular Mechanisms of Actions of Formulations of the Thyroid Hormone Analogue, Tetrac, on the Inflammatory Response. Endocrine Research 38:112-118.
  9. DJ Bharali, M Yalcin, PJ Davis, SA Mousa (2013) Tetraiodothyroacetic Acid-Conjugated Plga Nanoparticles: A Nanomedicine Approach to Treat Drug-Resistant Breast Cancer. Nanomedicine (London) 8:1943-1954.
  10. DJ Bharali, SA Mousa (2013) Relevance of Nanotechnology in Modulating Oxidative Stress: An Overview. Methods in Molecular Biology 1028:289-292.
  11. DJ Bharali, D Armstrong, SA Mousa (2013) Hybrid Polymeric Nanoparticles: Potential Candidate for Ophthalmic Delivery. Methods in Molecular Biology 1028:279-286.
  12. T Sudha, P Phillips, C Kanaan, RJ Linhardt, L Borsig, SA Mousa (2012) Inhibitory Effect of Non-Anticoagulant Heparin (S-Nach) on Pancreatic Cancer Cell Adhesion and Metastasis in Human Umbilical Cord Vessel Segment and in Mouse Model. Clin Exp Metastasis 29:431-439.
  13. MH Qari, U Dier, SA Mousa (2012) Biomarkers of Inflammation, Growth Factor, and Coagulation Activation in Patients with Sickle Cell Disease. Clinical and Applied Thrombosis/Hemostasis 18:195-200.
  14. SA Mousa, M Yalcin, DJ Bharali, R Meng, HY Tang, HY Lin, FB Davis, PJ Davis (2012) Tetraiodothyroacetic Acid and Its Nanoformulation Inhibit Thyroid Hormone Stimulation of Non-Small Cell Lung Cancer Cells in Vitro and Its Growth in Xenografts. Lung Cancer 76:39-45.
  15. SA Mousa (2012) The Future of Anticoagulant Therapy. Cardiovascular Therapeutics 30:255-256.
  16. HY Lin, HY Tang, FB Davis, SA Mousa, S Incerpi, MK Luidens, R Meng, PJ Davis (2012) Nongenomic Regulation by Thyroid Hormone of Plasma Membrane Ion and Small Molecule Pumps. Discovery Medicine 14:199-206. Nongenomic Regulation by Thyroid Hormone
  17. MS Jayaraman, DJ Bharali, T Sudha, SA Mousa (2012) Nano Chitosan Peptide as a Potential Therapeutic Carrier for Retinal Delivery to Treat Age-Related Macular Degeneration. Molecular Vision 18:2300-2308.
  18. A Aljada, SA Mousa (2012) Metformin and Neoplasia: Implications and Indications. Pharmacology & Therapeutics 133:108-115.